V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330010250 | 330004630 | 1.79 | 73.3 | Not known (9) | 2013-09-24 | 2013-09-28 | CARBOPLATIN + RT | 02 | N | 330012763 | CARBOPLATIN + RT |
| 330010251 | 330004634 | 1.48 | 65.6 | Curative (C) | 2014-10-30 | 2014-10-30 | Cetuximab + Radiotherapy Maint | 02 | N | 330012785 | CETUXIMAB + RT |
| 330010252 | 330004636 | 0 | 84.4 | Palliative (P) | 2016-03-11 | 2016-04-19 | DACTINOMYCIN + IFOSFAMIDE + MESNA + VINCRISTINE | 2 | N | 330012799 | VAI |
| 330010253 | 330008524 | 1.64 | 84.2 | Palliative (P) | 2018-06-12 | 2018-06-12 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 330012800 | CARBOPLATIN + PACLITAXEL |
| 330010254 | 330004638 | 1.5 | null | Palliative (P) | 2014-08-03 | 2014-10-23 | Carboplatin + Etoposide iv&po | N | N | 330012805 | CARBOPLATIN + ETOPOSIDE |
| 330010255 | 330004642 | 1.68 | null | Palliative (P) | null | 2015-09-24 | BENDAMUSTINE + RITUXIMAB | null | null | 330012807 | BENDAMUSTINE + RITUXIMAB |
| 330010256 | 330004643 | 1.66 | 81 | Neo-adjuvant (N) | 2015-08-17 | 2015-08-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012816 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010257 | 330004644 | 0 | 66 | Curative (C) | 2016-06-19 | 2016-06-23 | CARBOPLATIN + RT | 2 | null | 330012817 | CARBOPLATIN + RT |
| 330010258 | 330004645 | 1.82 | 100.3 | Curative (C) | 2013-06-26 | 2013-11-17 | EURAMOS TRIAL | N | N | 330012823 | EURAMOS TRIAL |
| 330010259 | 330004649 | 1.6 | 59.2 | Disease modification (D) | 2016-06-18 | 2016-08-06 | Bendamustine+Rituximab(Sub Courses) | 02 | Y | 330012848 | BENDAMUSTINE + RITUXIMAB |
| 330010260 | 330008532 | 1.66 | 91.8 | Palliative (P) | 2017-07-29 | 2017-08-03 | Paclitaxel (2 or 3 weekly) | 1 | N | 330012852 | PACLITAXEL |
| 330010261 | 330004651 | 1.65 | 104 | Disease modification (D) | 2014-11-01 | 2015-09-13 | ALL UKALL2011 Maintenance B3 | 02 | Y | 330012858 | UKALL2011 |
| 330010262 | 330012442 | 1.77 | 43.8 | Disease modification (D) | 2017-04-09 | 2017-04-09 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012860 | CARBOPLATIN + PACLITAXEL |
| 330010263 | 330004657 | 0 | 14.9 | Curative (C) | 2015-09-01 | 2015-09-04 | Paclitaxel (2 or 3 weekly) | N | N | 330012880 | PACLITAXEL |
| 330010264 | 330004659 | null | 29.6 | Palliative (P) | null | 2018-09-26 | Cetuximab + Radiotherapy Maint | null | null | 330012900 | CETUXIMAB + RT |
| 330010265 | 330004661 | 1.72 | 50.7 | Neo-adjuvant (N) | 2014-11-20 | 2014-11-25 | Carboplatin + Etoposide iv&po | N | null | 330012903 | CARBOPLATIN + ETOPOSIDE |
| 330010266 | 330004662 | 0 | 30.2 | Curative (C) | 2015-02-22 | 2015-04-03 | Cetuximab + Radiotherapy Load | 2 | null | 330012908 | CETUXIMAB + RT |
| 330010267 | 330004665 | 1.75 | 123.2 | Palliative (P) | 2017-04-16 | 2017-04-21 | VAI (Ifos 3g/m2) | 02 | N | 330012915 | VAI |
| 330010268 | 330004665 | null | 54.1 | Palliative (P) | 2018-09-01 | 2018-09-26 | Carboplatin + Paclitaxel (weekly) | N | Y | 330012915 | CARBOPLATIN + PACLITAXEL |
| 330010269 | 330012816 | 1.7 | 93.1 | Disease modification (D) | 2016-04-16 | 2016-05-08 | BENDAMUSTINE + RITUXIMAB | N | Y | 330012923 | BENDAMUSTINE + RITUXIMAB |
| 330010270 | 330004667 | null | 73 | Palliative (P) | null | 2017-03-24 | ALL UKALL2011 Del Int B Pt1 (PAsp) | N | null | 330012926 | UKALL2011 |
| 330010271 | 330004668 | 1.63 | 67.1 | Palliative (P) | 2013-04-02 | 2013-04-02 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 330012934 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010272 | 330008542 | null | 51 | Palliative (P) | 2015-10-14 | 2015-10-18 | Paclitaxel (2 or 3 weekly) | null | N | 330012935 | PACLITAXEL |
| 330010275 | 330010632 | 1.78 | 56.4 | Neo-adjuvant (N) | 2016-07-30 | 2016-10-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012973 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010276 | 330004674 | 1.57 | 65.8 | Disease modification (D) | 2017-04-24 | 2017-04-24 | VAI (Ifos 3g/m2) | 2 | N | 330012974 | VAI |
| 330010277 | 330008549 | 1.58 | 46.9 | Palliative (P) | 2016-03-29 | 2016-04-01 | ALL UKALL2011 Maintenance A1 | N | N | 330012994 | UKALL2011 |
| 330010278 | 330010636 | 1.71 | 58.4 | Not known (9) | 2016-01-09 | 2016-01-12 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330012997 | CARBOPLATIN + PACLITAXEL |
| 330010279 | 330010636 | 0 | 28 | Neo-adjuvant (N) | 2015-10-29 | 2015-11-05 | CARBOPLATIN + FLUOROURACIL | N | N | 330012997 | CARBO + FLUOROURACIL |
| 330010280 | 330004679 | 0 | 108.2 | Curative (C) | 2016-12-06 | 2016-12-06 | ALL UKALL2011 Maintenance A3 | N | N | 330013003 | UKALL2011 |
| 330010281 | 330004682 | null | null | Palliative (P) | 2014-04-19 | 2014-04-19 | Paclitaxel 80mg/m2 day 1 8 15 | null | Y | 330013004 | PACLITAXEL |
| 330010282 | 330008552 | 0 | null | Palliative (P) | 2017-01-07 | 2017-01-18 | ALL UKALL2011 Maintenance A1 | N | N | 330013004 | UKALL2011 |
| 330010283 | 330004684 | 1.68 | 58 | Palliative (P) | 2018-05-25 | 2018-05-25 | ALL UKALL2011 Maintenance A1 | N | N | 330013060 | UKALL2011 |
| 330010284 | 330004686 | 1.77 | 90 | null | 2017-01-08 | 2017-02-18 | CARBOPLATIN + ETOPOSIDE | N | Y | 330013066 | CARBOPLATIN + ETOPOSIDE |
| 330010285 | 330004689 | 1.62 | null | Palliative (P) | 2017-01-27 | 2017-01-29 | ALL UKALL2011 Maintenance A1 | 02 | N | 330013074 | UKALL2011 |
| 330010286 | 330004691 | 1.74 | 41.4 | Palliative (P) | 2017-12-03 | 2017-12-04 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 330013076 | PACLITAXEL |
| 330010287 | 330004692 | 1.65 | null | Palliative (P) | null | 2017-11-24 | Carbo F | N | null | 330013082 | CARBO + FLUOROURACIL |
| 330010288 | 330004693 | 1.64 | 107 | Palliative (P) | 2017-02-21 | 2017-02-26 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 330013092 | CARBOPLATIN + PACLITAXEL |
| 330010289 | 330004696 | null | 41.9 | Curative (C) | 2017-09-30 | 2017-10-21 | CETUXIMAB + RT | 2 | N | 330013097 | CETUXIMAB + RT |
| 330010290 | 330004698 | 1.69 | 61 | Palliative (P) | 2019-01-20 | 2019-05-27 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330013098 | CARBOPLATIN + PACLITAXEL |
| 330010291 | 330004699 | 0 | 14.5 | Neo-adjuvant (N) | 2016-09-21 | 2016-10-04 | EURAMOS TRIAL | N | N | 330013105 | EURAMOS TRIAL |
| 330010292 | 330004702 | null | 101.6 | Palliative (P) | 2017-11-05 | 2017-11-10 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 330013109 | CARBOPLATIN + PACLITAXEL |
| 330010293 | 330010642 | 1.76 | 73.6 | Palliative (P) | null | 2014-12-06 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330013112 | BENDAMUSTINE + RITUXIMAB |
| 330010294 | 330012820 | 1.57 | 63.1 | Curative (C) | 2016-10-01 | 2017-04-08 | VAI (Ifos 3g/m2) | Y | N | 330013122 | VAI |
| 330010295 | 330004703 | 1.66 | 16.4 | Disease modification (D) | 2016-02-22 | 2016-06-03 | CARBOPLATIN + RT | Y | N | 330013123 | CARBOPLATIN + RT |
| 330010296 | 330004706 | 1.75 | 94 | Not known (9) | 2015-03-05 | 2015-05-27 | BENDAMUSTINE + RITUXIMAB | 02 | Y | 330013125 | BENDAMUSTINE + RITUXIMAB |
| 330010297 | 330008566 | 1.69 | 82.2 | Curative (C) | 2014-03-14 | 2014-03-14 | ALL UKALL2011 Std Int Maint A | Y | N | 330013135 | UKALL2011 |
| 330010298 | 330012452 | 0.52 | 60 | Palliative (P) | 2013-03-02 | 2013-04-09 | Carboplatin + Etoposide iv&po | N | N | 330013136 | CARBOPLATIN + ETOPOSIDE |
| 330010299 | 330013052 | 1.63 | 120 | Palliative (P) | 2015-04-19 | 2015-04-21 | BENDAMUSTINE + RITUXIMAB | 2 | Y | 330013139 | BENDAMUSTINE + RITUXIMAB |
| 330010300 | 330004709 | 1.88 | 72.8 | Curative (C) | 2015-04-20 | 2015-09-04 | EURAMOS TRIAL | N | N | 330013142 | EURAMOS TRIAL |
| 330010301 | 330004713 | null | 63.3 | Neo-adjuvant (N) | 2014-04-20 | 2015-05-30 | Carboplatin + Paclitaxel (3 weekly) | null | null | 330013155 | CARBOPLATIN + PACLITAXEL |